Methotrexate is a strong medicine. The FDA approved it to treat adults with severe, disabling psoriasis that cannot be controlled with medicine applied to the skin or light treatments. Methotrexate ...

Please provide your email address to receive an email when new articles are posted on . Patients with psoriasis taking methotrexate were 2.8 times more likely to develop nonmelanoma skin cancer than ...

Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...

An article published in the International Journal of Dermatology evaluated the drug survival of methotrexate in patients with psoriasis. This single-center retrospective study assessed the clinical ...

A consensus reached by nearly 200 international experts in dermatology supports specific methotrexate dosing recommendations for the treatment of psoriasis in most adults with the disorder and certain ...

Psoriasis is a condition in which skin cells are produced much faster than normal. The body cannot shed the cells fast enough, resulting in patches (plaques) of scaly, thick skin. Investigators ...

Patients with psoriasis taking methotrexate are nearly 3 times as likely to develop non-melanoma skin cancer than patients not taking the treatment. Patients with psoriasis who are treated with ...

He's had psoriasis for about 15 years. He has an [affected] body surface area of 4%, so moderate psoriasis. He's been treated with topical therapies by his dermatologist. Within the last year, he ...

When you have psoriasis, your immune system sends out signals that cause your skin cells to renew themselves too fast. This too-active immune response is what makes scales and red patches form on your ...

Briakinumab is a monoclonal antibody against the p40 molecule shared by interleukin-12 and interleukin-23, which is overexpressed in psoriatic skin lesions. We assessed the efficacy and safety of ...

In adults with psoriasis, adding methotrexate to adalimumab did not improve effectiveness or drug survival compared with adalimumab alone, according to a UK cohort study of patients with plaque ...